Table 1 Demographic and co-morbidity characteristics, COVID-19 infection related features, key management requirements and COVID-19 vaccination status of the study cohort. Bold text indicates subsection headings. (ICU - intensive care unit, SD - standard deviation)
From: Neurological disorders associated with COVID-19 in Sri Lanka
Characteristic | Â |
Mean age (SD, range), years | 50.6 (23.4, 1–89) |
|  | Number (%), N = 184 |
Males | 100 (54.3) |
Smoking | 11 (6.0) |
Alcohol excess | 11 (6.0) |
Pregnant | 3 (1.6) |
Immunosuppressant medication | 2 (1.1) |
Comorbidity | Number (%), N = 184 |
Hypertension | 54 (29.3) |
Diabetes | 47 (25.5) |
Ischaemic heart disease | 16 (8.7) |
Chronic kidney disease | 12 (6.5) |
Obesity | 11 (6.0) |
Chronic pulmonary disease | 9 (4.9) |
Dementia | 8 (4.3) |
Dyslipidaemia | 5 (2.7) |
Malignancy | 2 (1.1) |
Chronic liver disease | 2 (1.1) |
Cardiac failure | 1 (0.5) |
Other (craniopharyngioma, subarachnoid haemorrhage and dural arteriovenous fistula, mitral stenosis and pulmonary hypertension, epilepsy, renal transplant, gall bladder disease, thalassaemia, anaemia, Parkinson’s disease, mumps orchitis, venous ulcers, autoimmune encephalitis, rheumatoid arthritis) | 16 (8.7) |
No comorbidity | 56 (30.4) |
COVID-19 infection related features | Number (%), N = 176 |
Symptomatic | 130 (73.9) |
Features within symptomatic patients | Number (%), N = 130 |
COVID pneumonia | 61 (46.9) |
Anosmia | 26 (20.0) |
Sepsis | 18 (13.8) |
Ageusia | 10 (7.6) |
Deep vein thrombosis/Pulmonary embolism | 1 (0.8) |
COVID-19 infection management requirements | Number (%), N = 184 |
Supplemental oxygen | 52 (28.3) |
ICU Care | 12 (6.5) |
Non-invasive ventilation | 11 (6.0) |
Mechanical ventilation | 10 (5.4) |
COVID-19 vaccination status | Number (%), N = 184 |
Unvaccinated | 96 (52.2) |
Vaccinated—1 dose | 33 (17.9) |
Vaccinated—2 doses | 54 (29.3) |
Vaccinated—3 doses | 1 (0.5) |